CFTR and cystic fibrosis: Thus, drugs that can decrease the degradation of ΔF508 CFTR protein, increase the export of ΔF508 CFTR protein to the plasma membrane, and improve its ion channel function, would contribute to restoring the epithelial cell function and alleviating the associated symptoms of cystic fibrosis.